PRAP1

Across TCGA pan-cancer cohorts, PRAP1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated PRAP1 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher PRAP1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated PRAP1 expression acts as an unfavorable survival marker.

HNSC and ACC are the cancer types where PRAP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.191	0.751	.003	12	view →
ACC	DFS	Median	All	0.089	0.666	.010	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

PRAP1–HNSC (OS)

Open the HNSC breakdown →